PPIDT00114
Drug Information
| Name | Insulin glulisine |
|---|---|
| Sequence | GIVEQCCTSICSLYQLENYCN |
| DrugBank_ID | DB01309 |
| Type | biotech |
| Indication | Insulin glulisine is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Intravenous; Subcutaneous |
100 Units/ml
|
| Injection, solution | Intravenous; Subcutaneous |
100 [iU]/1mL
|
| Injection, solution | Parenteral; Subcutaneous |
100 U/ML
|
| Solution | Subcutaneous |
100 unit / mL
|
| Solution | Intravenous; Subcutaneous |
10000000 IU
|
| Solution | Subcutaneous |
100 IU
|
| Injection, solution | Subcutaneous |
100 U/ML
|
| Injection, solution | Subcutaneous |
3.49 mg
|
| Injection | Subcutaneous |
100 U/ml
|
| Injection, solution | Subcutaneous |
100 [iU]/1mL
|
| Injection, solution | Subcutaneous |
100 Units/mL
|
| Solution | Subcutaneous |
100 iu/1ml
|
| Solution | Parenteral |
100.000 UI
|
Target Information